A traditional Medicare out-of-pocket (OOP) cap could reduce beneficiaries’ costs but increase annual federal spending by $39 billion to $96 billion.
Commentary|Podcasts|June 19, 2025
Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays
Author(s)Maggie L. Shaw, Colin Banas, MD, MHA
Fact checked by: Skylar Jeremias
Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Advertisement
Today, we’re diving into the frustrating world of prior authorizations. Delays, denials, and endless paperwork—this process isn’t just a headache for providers; it’s a barrier for patients who need timely care.
Joining us is Colin Banas, MD, MHA, chief medical officer at DrFirst, who willl unpack why this system is broken and how we can fix it. From shocking patient delays to the surprising role of fax machines in 2025, we’ll explore why prior auths are driving burnout, potentially harming outcomes, and what’s being done to streamline the process.
Advertisement
Related to this article
MA-to-MA switching among dually eligible beneficiaries rose sharply from 2016 to 2022, AJMC study author Grace Mackleby, PhD, found.
CMS is adding value-based care (VBC) risk faster than many providers can build the data and tech capacity they need to succeed.
The article explores the use of dose-intensive IV iron replacement to achieve long-term hemoglobin stability in patients with moderate to severe HHT-related bleeding. The approach recognizes what the author calls "the relentless and recurrent nature of HHT-associated bleeding," and may help patients achieve better quality of life.
CMS finalized the mandatory GLOBE Model, tying Part B drug rebates to international prices in areas covering 25% of beneficiaries from Jan. 1, 2027.
FDA accepted United Therapeutics' sNDA for inhaled treprostinil in IPF. Here's what it could mean for patient access, coverage, and costs
Average stand-alone Part D premiums are projected to rise by less than $1 a month as a temporary subsidy program ends after 2026.
Advertisement
Advertisement
Trending on AJMC
1
Systemic Sclerosis Linked to Dramatic Rise in Lung Cancer Risk
2
FDA Approves First Heart Valve to Keep Pace With Children's Growth
3
Pipeline Advances in Sjögren Disease Bring Targeted Therapies Closer
4
Traditional Medicare OOP Cap Could Lower Costs, Raise Federal Spending
5